TY - JOUR
T1 - Artificial Intelligence Models Predict Operative Versus Nonoperative Management of Patients with Adult Spinal Deformity with 86% Accuracy
AU - International Spine Study Group
AU - Durand, Wesley M.
AU - Daniels, Alan H.
AU - Hamilton, David K.
AU - Passias, Peter
AU - Kim, Han Jo
AU - Protopsaltis, Themistocles
AU - LaFage, Virginie
AU - Smith, Justin S.
AU - Shaffrey, Christopher
AU - Gupta, Munish
AU - Klineberg, Eric
AU - Schwab, Frank
AU - Burton, Doug
AU - Bess, Shay
AU - Ames, Christopher
AU - Hart, Robert
N1 - Funding Information:
Conflict of interest statement: A.H.D. receives consulting fees from Stryker, Orthofix, Spineart, and EOS; research support from Southern Spine; and fellowship support from Orthofix. P.P. receives consulting fees from Medicrea and SpineWave; has speaking/teaching arrangements from Zimmer Biomet; is on the scientific advisory board at Allosource; and receives grants from the Cervical Spine Research Society. H.J.K. serves on the board of directors at AOSpine; receives fellowship support from AOSpine; receives research support from CSRS and ISSGF; receives royalties from K2M and Zimmer Biomet. T.P. receives consulting fees from Globus, Medicrea, Innovasis, K2M, and NuVasive. V.L. owns stock in Nemaris, Inc.; receives consulting fees from Globus; has speaking/teaching arrangements for DePuy Spine and K2M; and serves on the board of directors for Nemaris, Inc. J.S. receives grants from DePuy Synthes and royalties from Zimmer Biomet; owns stock in Alphatec; receives consulting fees from Zimmer Biomet, NuVasive, Cerapedics, and AllSource; and receives fellowship support from AOSpine and NREF. C.S. receives royalties from Medtronic, NuVasive, and Zimmer Biomet; owns stock in NuVasive; receives consulting fees from Medtronic; and receives fellowship support from NREF and AO. M.G. receives royalties from DePuy and Innomed; owns stock in J&J, P&G, and perform Biologics; is a consultant for DePuy and Medtronic; undertakes trips/travel for Alphatec and the Scoliosis Research Society; serves on the scientific advisory board for DePuy and Medtronic; and receives fellowship support from OMeGA and AOSpine. E.K. Receives consulting fees from DePuy Synthes, Stryker, and Medicrea; has speaking/teaching arrangements with AOSpine and K2M; and receives fellowship support from AOSpine. F.S. receives royalties from MSD and K2M; owns stock in Nemaris, Inc.; receives consulting fees from Zimmer Biomet, Globus Medical, MSD, K2M, and Medicrea; has speaking/teaching arrangements with Zimmer Biomet, MSD, Globus Medical, and K2M; and serves on the board of directors for Nemaris, Inc. D.B. receives royalties from DePuy Spine; is a consultant for DePuy Spine; serves on the board of directors for ISSG, SRS, and University of Kansas Physicians; and receives research support from DePuy Spine, Bioventus, and Pfizer. S.B. receives grants from K2, DePuy Spine, and Nuvasive; receives royalties from K2M; is a consultant for K2M; serves on the scientific advisory board for EOS and MISONIX; and receives grants from ISSGF. C.A. receives royalties from Stryker, Zimmer Biomet, DePuySynthes, Nuvasive, Next Orthosurgical, K2M, and Medicrea; is a consultant for DePuySynthes, Medtronic, Medicrea, and K2M; and receives research support from Titan Spine, DePuySynthes, and ISSG; and receives grants from SRS. R.H. receives royalties from Seaspine and DSS; is a consultant for Globus; and receives grants from ISSGF.
Funding Information:
Conflict of interest statement: A.H.D. receives consulting fees from Stryker, Orthofix, Spineart, and EOS; research support from Southern Spine ; and fellowship support from Orthofix . P.P. receives consulting fees from Medicrea and SpineWave; has speaking/teaching arrangements from Zimmer Biomet; is on the scientific advisory board at Allosource; and receives grants from the Cervical Spine Research Society . H.J.K. serves on the board of directors at AOSpine; receives fellowship support from AOSpine ; receives research support from CSRS and ISSGF ; receives royalties from K2M and Zimmer Biomet. T.P. receives consulting fees from Globus, Medicrea, Innovasis, K2M, and NuVasive. V.L. owns stock in Nemaris, Inc.; receives consulting fees from Globus; has speaking/teaching arrangements for DePuy Spine and K2M; and serves on the board of directors for Nemaris, Inc. J.S. receives grants from DePuy Synthes and royalties from Zimmer Biomet; owns stock in Alphatec; receives consulting fees from Zimmer Biomet, NuVasive, Cerapedics, and AllSource; and receives fellowship support from AOSpine and NREF . C.S. receives royalties from Medtronic, NuVasive, and Zimmer Biomet; owns stock in NuVasive; receives consulting fees from Medtronic; and receives fellowship support from NREF and AO. M.G. receives royalties from DePuy and Innomed; owns stock in J&J, P&G, and perform Biologics; is a consultant for DePuy and Medtronic; undertakes trips/travel for Alphatec and the Scoliosis Research Society; serves on the scientific advisory board for DePuy and Medtronic; and receives fellowship support from OMeGA and AOSpine . E.K. Receives consulting fees from DePuy Synthes, Stryker, and Medicrea; has speaking/teaching arrangements with AOSpine and K2M; and receives fellowship support from AOSpine . F.S. receives royalties from MSD and K2M; owns stock in Nemaris, Inc.; receives consulting fees from Zimmer Biomet, Globus Medical, MSD, K2M, and Medicrea; has speaking/teaching arrangements with Zimmer Biomet, MSD, Globus Medical, and K2M; and serves on the board of directors for Nemaris, Inc. D.B. receives royalties from DePuy Spine; is a consultant for DePuy Spine; serves on the board of directors for ISSG, SRS, and University of Kansas Physicians; and receives research support from DePuy Spine , Bioventus , and Pfizer . S.B. receives grants from K2 , DePuy Spine , and Nuvasive ; receives royalties from K2M; is a consultant for K2M; serves on the scientific advisory board for EOS and MISONIX; and receives grants from ISSGF . C.A. receives royalties from Stryker, Zimmer Biomet, DePuySynthes, Nuvasive, Next Orthosurgical, K2M, and Medicrea; is a consultant for DePuySynthes, Medtronic, Medicrea, and K2M; and receives research support from Titan Spine , DePuySynthes , and ISSG ; and receives grants from SRS . R.H. receives royalties from Seaspine and DSS; is a consultant for Globus; and receives grants from ISSGF .
Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2020/9
Y1 - 2020/9
N2 - Objective: Patients with ASD show complex and highly variable disease. The decision to manage patients operatively is largely subjective and varies based on surgeon training and experience. We sought to develop models capable of accurately discriminating between patients receiving operative versus nonoperative treatment based only on baseline radiographic and clinical data at enrollment. Methods: This study was a retrospective analysis of a multicenter consecutive cohort of patients with ASD. A total of 1503 patients were included, divided in a 70:30 split for training and testing. Patients receiving operative treatment were defined as those undergoing surgery up to 1 year after their baseline visit. Potential predictors included available demographics, past medical history, patient-reported outcome measures, and premeasured radiographic parameters from anteroposterior and lateral films. In total, 321 potential predictors were included. Random forest, elastic net regression, logistic regression, and support vector machines (SVMs) with radial and linear kernels were trained. Results: Of patients in the training and testing sets, 69.0% (n = 727) and 69.1% (n = 311), respectively, received operative management. On evaluation with the testing dataset, performance for SVM linear (area under the curve =0.910), elastic net (0.913), and SVM radial (0.914) models was excellent, and the logistic regression (0.896) and random forest (0.830) models performed very well for predicting operative management of patients with ASD. The SVM linear model showed 86% accuracy. Conclusions: This study developed models showing excellent discrimination (area under the curve >0.9) between patients receiving operative versus nonoperative management, based solely on baseline study enrollment values. Future investigations may evaluate the implementation of such models for decision support in the clinical setting.
AB - Objective: Patients with ASD show complex and highly variable disease. The decision to manage patients operatively is largely subjective and varies based on surgeon training and experience. We sought to develop models capable of accurately discriminating between patients receiving operative versus nonoperative treatment based only on baseline radiographic and clinical data at enrollment. Methods: This study was a retrospective analysis of a multicenter consecutive cohort of patients with ASD. A total of 1503 patients were included, divided in a 70:30 split for training and testing. Patients receiving operative treatment were defined as those undergoing surgery up to 1 year after their baseline visit. Potential predictors included available demographics, past medical history, patient-reported outcome measures, and premeasured radiographic parameters from anteroposterior and lateral films. In total, 321 potential predictors were included. Random forest, elastic net regression, logistic regression, and support vector machines (SVMs) with radial and linear kernels were trained. Results: Of patients in the training and testing sets, 69.0% (n = 727) and 69.1% (n = 311), respectively, received operative management. On evaluation with the testing dataset, performance for SVM linear (area under the curve =0.910), elastic net (0.913), and SVM radial (0.914) models was excellent, and the logistic regression (0.896) and random forest (0.830) models performed very well for predicting operative management of patients with ASD. The SVM linear model showed 86% accuracy. Conclusions: This study developed models showing excellent discrimination (area under the curve >0.9) between patients receiving operative versus nonoperative management, based solely on baseline study enrollment values. Future investigations may evaluate the implementation of such models for decision support in the clinical setting.
KW - Adult spinal deformity
KW - Operative management
KW - Predictive modeling
UR - http://www.scopus.com/inward/record.url?scp=85087356690&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087356690&partnerID=8YFLogxK
U2 - 10.1016/j.wneu.2020.05.099
DO - 10.1016/j.wneu.2020.05.099
M3 - Article
C2 - 32434029
AN - SCOPUS:85087356690
SN - 1878-8750
VL - 141
SP - e239-e253
JO - World Neurosurgery
JF - World Neurosurgery
ER -